News

Meda and GSK are also pursuing further discussions on additional OTC acquisitions in the US market. Meda is an international specialty pharma company engaged in marketing and product

PJP transforms proteins, peptides and delicate small molecules into drugs. It also designs optimised pharmaceutical formulations and delivery systems that are stable, convenient and safe. The company develops

Under the agreement, TRL and Anaphore will generate novel trivalent proteins called Atrimers that can be programmed to bind to and activate or inhibit targets of interest. The

Immunomedics and UCB said that each study will will randomise 780 subjects in the study, with approximately 130 planned investigational sites per study. The primary objective of the

FDA has advised that the consumers who have Man Up Now capsules should stop using them immediately. Synergy Distribution claims that Man Up Now is ‘herbal’ and ‘all

Lilly, in consultation with an independent data monitoring committee, recommended a ‘full clinical hold,’ because of safety concerns. Following the declaration of clinical hold no new or existing

Amgen has evaluated XGEVA (denosumab) versus placebo in 1,432 men with castrate-resistant prostate cancer in ‘147 study Phase 3 trial. In the trial, the overall survival was similar

Inimex Pharma claims IMX942 is the first of a new class of drugs known as Innate Defense Regulators (IDRs), which improve survival, ameliorate tissue damage and reduce bacterial

Garabedian has been vice president of corporate strategy at Celgene Corporation since July 2007 ans was responsible for Celgene’s strategic and financial plan and supported the executive management